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Abstract
Background: Type-I interferons (IFNs) are used to treat certain inflammatory diseases. Moreover, activation of type-I IFN-
signaling in immune cells inhibits the production of proinflammatory cytokines and activation of inflammasomes. However,
the molecular mechanisms remain largely unknown. Upon sensing cytosolic double-stranded DNA, the AIM2 protein forms
the AIM2-ASC inflammasome, resulting in activation of caspase-1. Given that the IFI16 and AIM2 proteins are IFN-inducible
and can heterodimerize with each other, we investigated the regulation of IFI16, AIM2, and inflammasome proteins by type-
I and type-II IFNs and explored whether the IFI16 protein could negatively regulate the activation of the AIM2 (or other)
inflammasome.
Methodology/ Principal Findings: We found that basal levels of the IFI16 and AIM2 proteins were relatively low in
peripheral blood monocytes (CD14
+) and in the THP-1 monocytic cell line. However, treatment of THP-1 cells with type-I
(IFN-a or b) or type-II (IFN-c) IFN induced the expression levels of IFI16, AIM2, ASC and CASP1 proteins. The induced levels of
IFI16 and AIM2 proteins were detected primarily in the cytoplasm. Accordingly, relatively more IFI16 protein bound with the
AIM2 protein in the cytoplasmic fraction. Notably, increased expression of IFI16 protein in transfected HEK-293 cells
inhibited activation of caspase-1 by the AIM2-ASC inflammasome. Moreover, the constitutive knockdown of the IFI16
expression in THP-1 cells increased the basal and induced [induced by poly(dA:dT) or alum] activation of the caspase-1 by
the AIM2 and NLRP3 inflammasomes.
Conclusions/Significance: Our observations revealed that the type-I and type-II IFNs induce the expression of IFI16, AIM2,
and inflammasome proteins to various extents in THP-1 cells and the expression of IFI16 protein in THP-1 cells suppresses
the activation of caspase-1 by the AIM2 and NLRP3 inflammasomes. Thus, our observations identify the IFI16 protein as a
mediator of the anti-inflammatory actions of the type-I IFNs.
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Introduction
The interferons (IFNs) are a family of cytokines [1,2]. The
family includes type-I (IFN-a and b), type-II (IFN-c), and type III
IFNs [1,3]. IFNs exert multiple biological effects on cells through
binding to cell surface receptor and activating the IFN-signaling
[1]. The binding of the type I IFNs (a and b) to the cell surface
receptor results in activating phosphorylation of signal transducer
and activator of transcription 1 (STAT1) protein in the cytoplasm,
which then translocates to the nucleus and activates the
transcription of the IFN-inducible genes, such as the IFI16 and
AIM2 [4]. The proteins encoded by the IFN-inducible genes
mediate various biological and immunomodulatory activities of
the IFNs [1,5].
Most cell types produce low constitutive levels of type I IFNs
[2]. However, their expression is induced as a part of an innate
immune response that is initiated after infections [1,2]. Type I
IFNs are used to treat certain autoimmune and inflammatory
diseases, such as multiple sclerosis (MS) [6], familiar Mediterra-
nean fever (FMF) [7], and Behcet’s syndrome [8]. Notably,
increased serum levels of type I IFN (IFN-a) in individuals are
associated with increased risk to develop systemic lupus erythe-
matosus (SLE) [9,10], an autoimmune disease with systemic
inflammation [11]. The above observations are consistent with an
anti-inflammatory as well as an inflammatory role for the type I
IFNs. However, the molecular mechanisms remain largely
unknown.
The IFN-inducible p200-family proteins are encoded by the
murine (for example, Ifi202a, Ifi202b, and Aim2) and human (for
example, IFI16 and AIM2) genes [4,12]. These proteins share
either one or two partially conserved repeats of 200-amino acid
residues (HIN-200-aa domain) towards the C-terminus. The
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ride-binding folds (OB-folds) [13], which allow binding to double-
stranded DNA (dsDNA) in sequence independent manner [14].
Surprisingly, only the Aim2 protein in the family is conserved
(55% amino acid identities) between mice and humans [15]. Most
p200-family proteins (except the p202a and b proteins) also
contain a PYRIN domain (PYD) in the N-terminus [15]. The PYD
in the AIM2 protein allows heterodimerization with other p200-
family proteins, including the p202 [16] and IFI16 [17] proteins.
Given that most of the p200-family proteins contain both PYD
and HIN200 domains, these proteins are also referred as the
PYHIN proteins [18].
Several recently identified proteins sense cytosolic double-
stranded DNA (dsDNA). These proteins include DAI [19], RNA
polymerase III [20], and LRRFIP1 [21]. Additionally, the AIM2
[22-24] and IFI16 [25] PYHIN proteins can also sense cytosolic
DNA. Moreover, the AIM2 protein is required for innate immune
recognition of Francisella tularensis [26]. Upon sensing cytosolic
dsDNA, the AIM2 protein undergoes a conformational change
and recruits apoptosis speck like protein containing a CARD
(ASC) domain through its PYD. The ASC protein then interacts
with caspase-1 through its CARD domain. The resulting protein
complex, which is termed inflammasome [27], serves as a
molecular platform that mediates the autoactivation of caspase-
1, resulting in a ,20 kDa (p20) protein fragment. When activated,
the caspase-1 cleaves the pro-forms of the inflammatory cytokines,
such as IL-1b and IL-18, to active forms [27]. Interestingly, type I
interferon signaling is required for the activation of the AIM2
inflammasome during Francisella tularensis infection [24]. Excessive
secretion of IL-1b and IL-18 cytokines is linked to an increasing
number of human inflammatory diseases [28]. For example, an
inflammasome is constitutively activated with cleavage of caspase-
1 in human melanoma cells [29]. In contrast to the constitutive
activation of an inflammasome, the lack of activation is also
predicted to result in defective innate immune responses, increased
constitutive production of the IFN-b, and the development of
autoimmunity [30,31].
Upon sensing cytosolic dsDNA, the IFI16 protein is reported to
recruit the stimulator of interferon genes (STING) protein to
stimulate the expression of IFN-b through the activation of the
transcriptional activity of IRF3 and NF-kB in macrophage cell line
THP-1 [25]. In contrast, upon infection of endothelial cells with
Kaposi sarcoma-associated herpesvirus (KSHV), the IFI16 protein
is reported to sense the viral DNA in the nucleus to induce the
activation of caspase-1 and inflammasome [32]. Notably,
increased levels of IFI16 protein in human normal diploid
fibroblasts (HDFs) [33] and prostate epithelial cells [34] are
associated with the onset of cellular senescence. Interestingly,
reduced levels of the IFI16 protein in senescent (versus young or
old) HDFs are associated with senescence-associated secretory
phenotype (SASP) [35]. The secretory phenotype in the senescent
cells is associated with the activation of NF-kB activity and the
expression of target genes, which encode for the proinflammatory
cytokines [36].
A recent study indicated that activation of type I IFN-signaling
in bone marrow-derived macrophages (BMDMs) can inhibit the
production of interleukin-1 (IL-1) by inflammasomes, such as the
NLRP1 and NLRP3, through the STAT1-dependent mechanism
[37]. Additionally, the study showed that the activation of type I
IFN-signaling in BMDMs reduced the constitutive levels of the
pro-IL-1b, thus, explaining the effectiveness of the type I IFN (the
IFN-b) in the treatment of the inflammatory diseases [37].
However, the IFN-inducible protein(s) that mediates the anti-
inflammatory functions of the type I IFN remain to be identified.
Given that the expression of both AIM2 and IFI16 innate
immune sensors for the cytosolic DNA is induced by type I IFNs in
certain cell types and the activation of type I IFN-signaling can
inhibit the production of IL-1b [37], we explored the potential role
of the IFI16 protein in the regulation of the AIM2 inflammasome.
Here we report that the type I and II IFNs up-regulate the
expression of IFI16 and AIM2 proteins to different extents and
that the IFI16 protein suppresses the activation of caspase-1 by the
AIM2 and NLRP3 inflammasomes.
Materials and Methods
Cells and Treatments
Frozen human peripheral blood mononuclear cells (PBMCs),
purified CD14+ monocytes and CD19+ B cells were purchased
from ReachBio (Seattle, WA). THP-1 cells were purchased from
the American Type Culture Collection (ATCC; Manassas, VA).
Cultures of THP-1 cells were maintained (CO2, 5.5%) in RPMI-
1640 culture medium (cat # 30-2001, purchased from ATCC)
with high glucose, which was supplemented with 10% fetal bovine
serum and antibiotics (Invitrogen, Carlsbad, CA). Differentiation
of THP-1 cells was induced as described previously [24]. Briefly,
THP-1 cells were incubated with 1 mM PMA for 3 h or 20 nM
for overnight and then the cells were washed with PBS and were
allowed to adhere to the surface of the tissue culture plates.
Human embryonic kidney cells (HEK-293T) were purchased from
ATCC and maintained in DMEM with high glucose (Invitrogen).
The medium was supplemented with 10% fetal bovine serum
(Invitrogen).
PMA differentiated THP-1 cells were primed with LPS
(100 ng/ml, Sigma) for 3–4 h, followed by stimulation of the
NLRP3 inflammasome with alum (Sigma; 300 mg/ml for
150 min) as described previously [37].
Transfections and Expression Vectors
Transient transfections in HEK-293T cells were performed
using Lipofectamine 2000 (Invitrogen #11668-027) as suggested
by the supplier. The transfected cells were harvested after 40–45 h
of transfections. The following expression plasmids, which allowed
the expression of the FLAG-tagged proteins (the tag at the
C-terminus of the proteins), were purchased from OriGene
(Rockville, MD): hAIM2 (NM_004833), hASC (NM_013258),
and Caspase1 (NM_033293). The pCDNA3-IFI16B plasmid has
been described previously [34].
Nucleofections
THP-1 cells (,2610
6 cells/ nucleofection) were nucleofected as
described previously (37). In brief, cells were nucleofected with
2 mg of synthetic DNA [poly(dA:dT); from InvivoGen, San Diego,
CA] using the Nucleofector-II device (Amaxa Biosystems,
Natthermannalle 1, Germany). We used nucleofection kit-V and
program U-001. These nucleofection conditions resulted in ,60%
cell survival. After nucleofections, cells were harvested at the
indicated time for immunoblotting.
Knockdown of IFI16 Expression
THP-1 cells were either infected with control lentiviral particles
(sc-108080; from Santa Cruz Biotech, Santa Cruz,, CA) or the
lentiviral particles expressing shIFI16 RNA (sc-35633-V, Santa
Cruz Biotech) in a six well plate as suggested by the supplier. A day
after infections, cells were selected with puromycin (0.5–1 mg/ml)
for about a week. The selected cells were pooled and maintained
in puromycin (0.5 mg/ml) for another week. At the end of
puromycin selection, cells were serially diluted to isolate clonal cell
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for the knockdown of IFI16 expression by quantitative real-time
PCR as well as immunoblotting. We were able to identify at least
three clonal cell populations in which we achieved ,80–90%
knockdown of IFI16 expression. For experiments, cells were
cultured without puromycin for at least three days.
Immunoblotting
Total cell lysates were prepared and analyzed by immunoblot-
ting as described previously [38]. Endogenous AIM2 protein was
detected by rabbit polyclonal antibodies that were raised against
the KLH conjugated hAIM2 C-terminal peptide (GVHSTIKVI-
KAKKKT). This antibody preparation detected a protein band
,48 kDa, which was induced by treatment of cells with interferon
[35]. Antibodies specific for IFI16 (sc-8023) and ASC (sc-22514)
proteins were purchased from Santa Cruz Biotech. Antibodies
specific for b-actin (cat # 4967), IkBa (# 9247); histone 3 (#
9715); caspase 1 (# 3866); and IL-1b (# 2022) were purchased
from Cell Signaling Technology (Danvers, MA). Anti-FLAG
antibodies (# TA0011) were purchased from OriGene. FLAG-
tagged proteins were immunoprecipitated using an immunopre-
cipitation kit (cat # A8592) purchased from Sigma-Aldrich (St
Louis, MO). The tagged protein was eluted from the immuno-
precipitation beads using the FLAG peptide as suggested by the
supplier. Horseradish peroxidase (HRP) conjugated secondary
anti-mouse (NXA-931) and anti-rabbit (NA-934) antibodies were
from Amersham Biosciences.
Reverse Transcriptase Reaction, Real-time PCR
Total RNA was isolated from THP-1 cells with Trizol reagent
(Invitrogen, Carlsbad, CA, USA). cDNA synthesis, RT-PCR and
quantitative real-time TaqMan PCR were performed as described
previously [39]. The following primers were used for RT-PCR: hIL-
1b (forward: 59- CTCG CCAGTGAAATGATG GCT -39;
backward: 59-GTCGGAGATTCGTAGCTGGAT- 39); hAIM2
(Forward: 59-ATGTG AAGCCGTCCAGA-39; backward: 59-CAT-
CATTTCTGA TGGCTGCA-39); IFI16 (forward: 59-CCAA-
GACTGAAGACTG AA-39; backward: 59-ATCGT CAATGACA
TCCAG-39); and Actin (forward: 59-GCTCGTCGTCGACAA-
CGGCTC-39;b a c k w a r d :5 9-CATGATCTGGGTCA TCTTCTC-
39).The following TaqMan gene-specific assays were purchased from
the Applied Biosystems (Foster City, CA) and used as suggested by
the supplier: AIM2 (Hs 00175457_m1), IFI16 (Hs 00194261_m1),
ASC (Hs 00203118_m1), Caspase-1 (Hs 01554467_m1), IL-1b
(Hs01555410_m1), and the endogenous control b-actin (assay Id#
Hs99999903_ml).
Cell Fractionations
Cytosolic and nuclear fractions were essentially prepared as
described previously (40). Briefly, cell pellet were incubated for
10 min on ice in cell fractionation buffer (20 mM Tris-HCl, pH 7.5;
0.65% NP-40, 150 mM NaCl) containing protease and phosphatase
inhibitors. The cytosolic fractions were collected by centrifuging the
resultant cell lysate at 4000 rpm for 5 min in a refrigerated micro-
centrifuge. The reaming nuclear pellet was washed with the cell
fractionation buffer; the nuclear pellet was lysed by suspending into
the RIPA buffer followed by brief sonication [39].
Statistical Analyses
The measurement values are presented as means6SEM. The
statistical significance of differences in the measured mean
frequencies between the two groups was calculated using the
Student’s two-tailed t test.
Results
Expression of the IFI16 and AIM2 Proteins is Cell Type
Dependent
An earlier study [41] reported that monocytic (CD14
+) cells
from peripheral blood stain positive for the expression of IFI16
protein in two color cytofluorography. Moreover, treatment of
THP-1 cells, a monocytic cell line, with PMA was reported to
increase steady-state levels of the AIM2, but not IFI16, mRNA
[22]. Therefore, to begin to investigate the potential role of the
IFN-inducible IFI16 protein in the regulation of the AIM2
inflammasome, we compared steady-state basal levels of the IFI16,
AIM2, inflammasome proteins (ASC and procaspase-1), and IL-
1b in peripheral blood-derived mononuclear cells (PBMCs),
purified monocytes (CD14
+), and purified B lymphocytes
(CD19
+). As shown in Fig. 1A, the basal steady-state levels of
Figure 1. Expression of the IFI16 and AIM2 proteins is cell type dependent. (A) Total cell extracts containing equal amounts of proteins
from peripheral blood mononuclear cells (PBMNC), purified monocytes (CD14
+), or B lymphocytes (CD19
+) were analyzed by immunoblotting using
antibodies specific to the indicated proteins. The arrowheads indicate different forms of the AIM2 (53 and 49 kDa) and IFI16 (A, B, and C forms)
proteins. (B) Total RNA was extracted from total PBMNCs, purified CD14
+ or CD19
+ cells. Steady state levels of the IFI16 or AIM2 mRNA were analyzed
by quantitative TaqMan real-time PCR. The ratio of the test gene to actin mRNA was calculated in units (one unit being the ratio of the test gene to
actin mRNA). Results are mean values of triplicate experiments and error bars represent standard deviation. (C) Total RNA as described in panel (B)
was also analyzed by the quantitative TaqMan real-time PCR for the IFN-b mRNA. Again, the ratio of the test gene to actin mRNA was calculated in
units. Results are mean values of triplicate experiments and error bars represent standard deviation.
doi:10.1371/journal.pone.0027040.g001
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monocytes. However, the expression of both IFI16 and AIM2
proteins was readily detectable in the B lymphocytes. As expected
[42], we detected all three isoforms (the A, B, and C) of the IFI16
protein in B lymphocytes. However, in contrast to our expecta-
tions [35], we detected two AIM2 protein bands in B lymphocytes,
which migrated close to each other. Presently, it is not clear
whether the slow-migrating protein band that was detected by the
AIM2-specific antibody is a modified form of the AIM2 protein or
an alternatively spliced isoform [15]. Moreover, the basal levels of
the ASC and procaspase-1 were detectable in PBMCs and
monocytes. Interestingly, we were able to detect the constitutive
levels of activated caspase -1 (the p20 protein band) in extracts
from PBMCs and monocytes, but not B lymphocytes.
Consistent with our above observations steady-state levels of the
IFI16 and AIM2 mRNA were relatively lower in the monocytes as
compared to B lymphocytes (Fig. 1B). Accordingly, levels of the
IFN-b mRNA were lower in monocytes as compared to peripheral
B cells (Fig. 1C). Together, these observations indicate that the
basal levels of the IFI16 and AIM2 proteins depend on the
immune cell-type and the peripheral blood monocytes express
very low basal levels of IFI16 and AIM2 proteins.
IFNs Differentially Induce the Expression of the AIM2 and
Pro-IL-1b
The above observations that the basal levels of IFI16 and AIM2
proteins are not detectable in the peripheral blood monocytes
prompted us to investigate whether IFN-treatment could up-
regulate their expression. For this purpose, we chose to use THP-1
cells for several reasons: (i) these cells resemble the primary
monocytes in that they constitutively express detectable levels of
ASC adaptor protein and procaspase-1 [27]; (ii) cells are well-
characterized with respect to inflammasome activation and its
regulation [27,37]; (iii) the expression of IFI16 protein can be
induced by treatment of PMA-treated THP-1 cells with either type
I or II IFNs [43]; (iv) a decrease in the AIM2 expression in THP-1
cells impaired dsDNA-induced maturation of IL-1b, which
indicated that the endogenous AIM2 protein is required for
DNA recognition [22]. Although, IFN-b treatment of THP-1 cells
increases levels of the AIM2 mRNA [22], it remains unknown
whether the IFN-b (or IFN-c) treatment of these cells can also
induce the expression of mRNA encoding for the IFI16 and/or
inflammasome proteins, such as ASC and procaspase-1. As shown
in Fig. 2, consistent with our above observations, basal levels of the
IFI16, AIM2, and procaspase-1 mRNA were either very low or
undetectable in untreated THP-1 cells. However, the basal levels
of mRNAs encoding for the adaptor protein ASC and IL-1b were
detectable. Interestingly, treatment of THP-1 cells with type I IFN
(IFN-a or b) or type II IFN (IFN-c) increased the steady-state
levels of mRNAs encoded by the IFI16, AIM2 and P-CASP1 genes
to different extents (Fig. 1A and 1B). The IFN-a treatment
appreciably increased the steady-state levels of the IFI16 and
CASP1 mRNA than the IFN-b or IFN-c. In contrast to our
expectations, the treatment of cells with IFN-c increased levels of
the AIM2 and pro-IL-1b mRNA measurably more than the type I
IFNs. Importantly, the treatment of cells with type I IFNs (IFN-a
or b) significantly decreased the steady-state levels of mRNA
encoding for the pro-IL-1b (Fig. 1A and 1B). Together, these
observations demonstrated that treatment of THP-1 cells with the
type I or type II IFN increases steady-state levels of the IFI16,
AIM2, CASP-1 mRNA whereas the treatment differentially
regulates the levels of pro-IL-1b mRNA.
IFNs and PMA Differentially Regulate the Expression of
the IFI16, AIM2, and Inflammasome Proteins and Their
Sub-cellular Localization
The expression levels of IFI16 protein are also regulated by
post-transcriptional mechanisms [42]. Therefore, we also ana-
lyzed basal and IFN-induced levels of the IFI16 and other
proteins. As shown in Fig. 3A, consistent with our above
observations, type I IFN treatment of cells induced IFI16 protein
levels more than the IFN-c treatment. Similarly, the IFN-c
treatment of cells induced levels of the AIM2 protein more than
the type I IFNs. Interestingly, as noted above, we also detected
two AIM2 protein bands in THP-1 cells. Again, consistent with
our above observations, levels of the ASC and proscaspase-1
proteins were moderately (,2-fold) increased by treatment of
cells by type I IFNs. However, the treatment of cells with IFN-c
reduced the levels of both of these proteins by ,50%. Moreover,
Figure 2. IFNs induce the expression of the IFI16, AIM2, and inflammasome genes. (A) Total RNA was extracted from THP-1 cells either left
untreated (control) or treated with IFN-a (Universal IFN; 1000 u/ml), IFN-b (1000 u/ml), or IFN-c (10 ng/ml) for 12 h. Relative steady-state levels of
mRNA were analyzed by semi-quantitative RT-PCR using a pair of primer specific to the indicated genes. FC, indicates the fold change in the steady-
state levels of the AIM2 or IL-1B mRNA as compared to the control (lane 1). (B) Total mRNA in panel (A) was also analyzed for steady-state levels of
mRNAs for the indicated genes by quantitative real-time PCR. The relative steady-state levels of the mRNA in control cells for each gene are indicated
as 1. Results are mean values of triplicate experiments and error bars represent standard deviation.
doi:10.1371/journal.pone.0027040.g002
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detectable in untreated or IFN-treated THP-1 cells (data not
shown).
Treatment of THP-1 cells with phorbol 12-myristate 13-
acetate (PMA) is reported to induce the expression of the AIM2,
but not IFI16, gene [22]. Given that type I IFN (IFN-b) treatment
of human diploid fibroblasts (HDFs) induces the expression of
both AIM2 and IFI16 proteins [35], we treated THP-1 cells with
PMA, IFN-a, or both and analyzed the expression levels of the
IFI16 and AIM2 proteins. As shown in Fig. 3B, consistent with
the previous report [43], treatment of cells with PMA alone did
not induce the expression of IFI16 protein. However, the
treatment increased levels of the AIM2 protein, which migrated
slower than the form that was induced by the type I IFN
(compare lane 3 with 2). Notably, both forms of the AIM2 protein
were detected in cells that were treated with PMA and type I IFN
(compare lane 4 with lanes 2 and 3). Interestingly, the treatment
with PMA significantly decreased the basal levels of STAT1
transcription factor, adaptor protein ASC, and proscaspase-1.
Moreover, treatment of cells with type I IFN along with PMA
restored the expression of STAT1 and procaspase-1, but not the
ASC protein (compare lane 4 with 3).
Sub-cellular localization of both IFI16 and AIM2 proteins
appears to depend on the cell-type [15,42]. Given that the IFI16
protein heterodimerizes with the AIM2 protein [17,35], we
investigated the sub-cellular localization of basal and induced
levels of the IFI16, AIM2, and inflammasome proteins in THP-1
cells using cell fractionation approach. As shown in Fig. 3C, basal
low levels of the IFI16, AIM2, ASC, P-CASP1, and pro-IL-1b
proteins were detectable in the cytoplasmic fraction. Treatment
of cells with IFN-a or c, which induced levels of both IFI16 and
AIM2 proteins, revealed that the bulk of the proteins were
detected in the cytoplasmic fractions and only a small fraction
was detectable in the nuclear fraction. Interestingly, it is the slow-
migrating form of the AIM2 protein, which was detected in the
nuclear fraction. Moreover, consistent with the previous reports
[27], treatment of cells with PMA increased basal levels of pro-
IL-1b and IL-1b proteins. Notably, the IFN-b treatment of PMA-
differentiated THP-1 cells reduced the levels of the cleaved form
of IL-1b (compare lane 5 with 4 or 6). Together, these
observations revealed that IFNs and PMA differentially regulate
the levels of IFI16, AIM2, and inflammasome proteins.
Additionally, these observations indicated that the IFN-induced
levels of both IFI16 and AIM2 protein are detected primarily in
the cytoplasm.
IFI16 Protein Binds to AIM2 Protein in the Cytoplasmic
Fraction and Increased Levels of the IFI16 Protein Inhibit
the AIM2-ASC Inflammasome-mediated Activation of
Casapase-1
The IFI16 protein heterodimerizes with the AIM2 protein
[17,35]. Therefore, detection of both IFI16 and AIM2 proteins in
the cytoplasmic fraction as well as in the nuclear fraction of THP-1
cells prompted us to test their interactions in the two sub-cellular
compartments. As shown in Fig. 4A, we were able to immuno-
precipitate IFI16 protein that was bound to FLAG-tagged AIM2
protein in both cytoplasmic and nuclear fractions in transfected
HEK-293T cells. Interestingly, consistent with our above obser-
vations (Fig. 3), more AIM2 protein bound to the IFI16 protein in
the cytoplasmic fraction than the nuclear fraction. These
observations prompted us to test whether increased expression of
IFI16 protein could inhibit the AIM2-ASC-mediated activation of
Figure 3. IFNs and PMA differentially regulate the expression of the IFI16, AIM2, and inflammasome proteins and their sub-cellular
localization. (A) Total cell extracts were prepared from THP-1 cells either left untreated (control) or treated with IFN-a (Universal IFN; 1000 u/ml),
IFN-b (1000 u/ml), or IFN-c (10 ng/ml) for 12 h. Extracts containing approximately equal amounts of proteins were analyzed by immunoblotting
using antibodies specific to the indicated proteins. The arrowheads indicate different isoforms of IFI16 protein. FC, indicates the fold change in the
levels of the AIM2 protein with respect to the control (lane 1). (B) THP-1 cells were either left untreated (lane 1) or treated with IFN-a (1000 u/ml for
16 h) alone (lane 2), treated with PMA (1 mM for 3 h; lane 3) alone or both PMA and IFN-a (lane 4). After the treatment, total cell extracts containing
approximately equal amounts of proteins were analyzed by immunoblotting using antibodies specific to the indicated proteins. The arrowheads
indicate two protein bands (53 and 49 kDa) of the AIM2 protein. (C) THP-1 cells were either left untreated (lanes 1 and 7) or treated with IFN-a
(1000 u/ml for 16 h) alone (lanes 2 and 8), IFN-c (10 ng/ml for 16 h) alone (lanes 3 and 9), PMA (1 mM) alone (lanes 4 and 10), both PMA and IFN-a
(lanes 5 and 11), or PMA and IFN-c (lanes 6 and 12) . After the treatment, cells were fractionation into the cytoplasmic and nuclear fractions. The
fractions containing approximately equal amounts of proteins were analyzed by immunoblotting using antibodies specific to the indicated proteins.
Detection of the IkBa protein only in the cytoplasmic fraction and histone H3 in the nuclear fraction served as the quality control for the purity of cell
fractionations.
doi:10.1371/journal.pone.0027040.g003
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[27,44], increased expression of adaptor protein ASC in
transfected HEK-293T cells resulted in the generation of the
p20 form of the caspase-1, thus, indicating its activation [27].
Moreover, co-expression of the FLAG-tagged AIM2 protein
increased the cleavage of procaspase-1 (compare lane 3 with 2),
which decreased the levels of procaspase-1 ,50%. Importantly,
increased expression of the IFI16 protein in HEK-293T cells
reduced the activation of caspase-1 as determined by a reduction
in the levels of the p20 form of the caspase-1 (compare lane 4 or 5
with lane 3). Together, these observations indicated that the IFI16
protein binds to AIM2 protein in the cytoplasmic fraction and
increased expression of IFI16 protein in transfected cells can
inhibit the AIM2-ASC-mediated activation of caspase-1.
Knockdown of IFI16 Expression Increases the
Constitutive Levels of the Activated Casapase-1
The above observations that increased levels of IFI16 protein in
transfected cells inhibited the activation of caspase-1 by the AIM2-
ASC inflammasome encouraged us to investigate whether the
knockdown of the IFI16 expression in THP-1 cells could regulate
the expression and/or functions of the AIM2 (or other)
inflammasome. Therefore, we knockdown the expression of the
IFI16 protein in THP-1 cells and isolated three independent cell
populations (Fig. 5A). Moreover, as shown in Fig. 5B, the
knockdown of IFI16 protein reduced basal (compare lane 3 with
1) and the IFN-induced (compare lane 4 with 2) levels of IFI16
mRNA. Importantly, the IFN-induced levels of the AIM2 mRNA
did not decrease in THP-1 cells (Fig. 5B, compare lane 4 with 2).
These observations allowed us to compare basal and induced
(induced by IFN-b or LPS) levels of AIM2 and other inflamma-
some proteins between control THP-1 cells (infected with control
virus) and cells in which we had constitutively decreased the basal
levels of the IFI16 protein. As shown in Fig. 5C, consistent with
our above observations (Fig. 5A) the knockdown of the IFI16
expression in THP-1 cells decreased basal and induced (induced
by IFN-b, LPS, or double stranded RNA) levels of the IFI16
protein. Interestingly, the knockdown moderately (, 2-fold)
increased the basal levels of AIM2 and P-CASP1 proteins
(compare lane 5 with 1). Importantly, the knockdown increased
the basal levels of the activated caspase-1 as determined by
increases in the p20 protein band [27]. Together, these
observations support the idea that the expression of IFI16 protein
in THP-1 cells decreases the basal levels of the AIM2 and P-
CASP-1, and the activation of CASP-1.
Induction of IFN-b expression in THP-1 cells by poly(dA:dT)
treatment depends on the IFI16 expression [25]. Given that the
IFN-b treatment of the murine BMDMs induced IL-10 expression
in a STAT1-dependent manner and the increased production of
IL-10 through activation of STAT3 transcription factor reduced
the abundance of the pro-IL-1b [37], we explored whether the
knockdown of IFI16 expression in THP-1 cells could negatively
regulate the basal and IFN-b-mediated induction of IFNs and IL-
10 expression. As shown in Fig. 5D, the knockdown of IFI16
Figure 4. IFI16 protein binds to AIM2 protein in the cytoplasmic fraction and increased levels of the IFI16 protein inhibits the AIM2-
ASC inflammasome-mediated activation of casapase-1. (A) Cultures of human embryonic kidney cells (HEK-293) at ,80% confluency were
either transfected with pCMV-AIM2 plasmid (2 mg) allowing the expression of the FLAG-tagged human AIM2 protein or along with the pCMV-IFI16
plasmid (1 mg) allowing the expression of IFI16 protein. 40 h after the transfections, cells were fractionated into cytoplasmic and nuclear fractions and
fractions containing approximately equal amounts of proteins were subjected to immunoprecipitation using specific antibodies to the FLAG-tag. The
immunoprecipitates were analyzed by immunoblotting using antibodies to the FLAG-tag (the upper panel) or the IFI16 protein (the lower panel). The
fold change (FC) in the IFI16 protein levels in immunoprecipitates is also indicated. (B) Left panel: HEK-293 cells were either left untransfected (lane 1)
or transfected with plasmid DNAs encoding for the ASC (DNA 50 ng; lanes 2–5), CASP-1 (DNA 100 ng; lanes 2–5), AIM2 (200 ng; lanes 3–5), or IFI16
(200 or 400 ng; lanes 4 and 5 respectively) proteins. Total amount of plasmid DNA in the transfections was adjusted to 2 mg using the pCDNA3
plasmid DNA. About 40 h after the transfections, cell lysates were analyzed by immunoblotting using antibodies specific to the indicated proteins.
Right panel: Relative caspase-1 (p20) protein levels shown in the left panel (lanes 1–4).
doi:10.1371/journal.pone.0027040.g004
IFI16 as a Negative Regulator of Inflammasomes
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e27040expression in THP-1 cells decreased basal and IFN-induced levels
of mRNAs encoding for the IFN-a, IFN-b, and IFN-c. These
observations are consistent with the previous report [25]. Notably,
the knockdown of IFI16 expression also reduced the basal and the
induced levels of the IL-10 mRNA. These observations revealed
that the expression of IFI16 protein in THP-1 cells contributes to
the expression of these cytokines.
Knockdown of IFI16 Expression Increases the Activation
of Caspase-1 by Inflammasomes
Our above observations that the knockdown of IFI16 expression
in THP-1 cells increases the constitutive levels of activated
caspase-1 (the p20 form) encouraged us to test whether the
reduced levels of the IFI16 protein in cells potentiate the activation
of the AIM2 or NLRP3 inflammasome. Therefore, we used an
optimized protocol [27] to study the activation of the AIM2
inflammasome by dsDNA poly(dA:dT). As shown in Fig. 6A,
nucleofection of control or shIFI16 THP-1 cells (cells were treated
with PMA overnight and then primed with LPS for 3 h) with the
synthetic dsDNA increased the levels of activated caspase-1 (the
p20) (compare lane 2 with 1 or lane 4 with 3). Consistent with our
above observations, the constitutive levels of the caspase-1 (p20)
were higher in the shIFI16 cells than the control cells (compare
lane 3 with 1). Correspondingly, we detected lower levels of the
procaspase-1 in THP-1 cells after the knockdown of IFI16
expression. Interestingly, the knockdown of IFI16 expression
increased steady-state levels of the NLRP3 protein and the
activated caspase-1 (compare lane 3 with 1). Moreover, treatment
of the primed THP-1 cells with alum (an activator of the NLRP3),
which decreased levels of the pro-caspase-1 (compare lane 4 with
2), also decreased levels of the p20 (compare lane 4 with 3).
Together, these observations demonstrated that reduced levels of
IFI16 protein in PMA-induced differentiated THP-1 cells
potentiate dsDNA-mediated activation of the AIM2 inflamma-
some and alum-mediated activation of NLRP3 inflammasome.
Discussion
IFN-b is being used in the clinic to treat several inflammation-
associated diseases, including MS [6–8]. However, the molecular
mechanisms by which the IFN-b exerts its anti-inflammatory
effects remain largely unknown. Interestingly, inhibition of the
production of proinflammatory cytokine IL-1b by type I IFN in
immune cells provides a possible molecular basis for the anti-
inflammatory action of the IFN-b in MS patients [37]. However,
the IFN-inducible protein(s) that mediates the anti-inflammatory
actions remain to be identified.
Given that: (i) the expression of both AIM2 and IFI16 proteins
is induced by type I IFNs in certain cell types [15,42]; (ii) upon
sensing cytosolic dsDNA, only the AIM2, but not the IFI16,
protein can form an inflammasome to activate caspase-1 [15,25];
and (iii) both AIM2 and IFI16 proteins can form heterodimers
[17,35], we explored whether the IFI16 protein could negatively
regulate activation of caspase-1 by the AIM2-ASC (or other)
inflammasome. Our observations using the peripheral blood-
Figure 5. Knockdown of IFI16 expression increases the constitutive levels of the activated casapase-1. (A) Puromycin-resistant THP-1
cells either infected with control lentivirus (lanes 1 an2) or the virus expressing the shIFI16 RNA (lanes 3–8; cell populations from three different wells)
were either left untreated (lanes 1, 3, 5, 7) or treated with IFN-a for 14 h. After treatment, total cell extracts containing increased amounts of proteins
(,100 mg/lane) were analyzed for the constitutive and induced levels of IFI16 and actin proteins. A long exposure was taken to detect the signal in all
lanes. (B) Control THP-1 cells (lanes 1 and 2) or cell population from well # 9 (lanes 3 and 4) as shown in the panel (a) were either left untreated (lanes
1 and 3) or treated with IFN-a for 14 h (lanes 2 and 4). After the treatment, total RNA was analyzed for the steady-state levels of mRNA for the
indicated genes. (C) Control THP-1 cells (lanes 1–4) or cells infected with virus expressing the shIFI16 mRNA (lanes 5–8; population # 9) were either
left untreated (lanes 1 and 5) or treated with IFN-b (1,000 u/ml; lanes 2 and 6), LPS (100 ng/ml; lanes 3 and 7), or dsRNA (10 mg/ml; lanes 4 and 8) for
14 h. After the treatment, total cell lysates containing equal amounts of protein (,100 mg/lane) were analyzed by immunoblotting using specific
antibodies to the indicated proteins. FC, indicates the fold change in the levels of the activated caspase-1 (the p20 band) with respect to the control
(lane 1). (D) Control THP-1 cells or cells infected with virus expressing the shIFI16 mRNA (population # 9) were either left untreated (white columns)
or treated with IFN-b (1,000 u/ml; columns 2–5 and 7–10) for 14 h. After the treatment, total RNA levels were analyzed for the indicated genes by the
quantitative TaqMan real-time PCR. The ratio of the test gene to actin mRNA was calculated in units (one unit being the ratio of the test gene to actin
mRNA). Results are mean values of triplicate experiments and error bars represent standard deviation.
doi:10.1371/journal.pone.0027040.g005
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+) and well-characterized THP-1
monocytic cell line revealed that (i) the expression of IFI16 and
AIM2 proteins is cell type-dependent (Fig. 1); (ii) type I and II
IFNs induce the expression of the IFI16, AIM2, and inflamma-
some proteins and corresponding mRNAs (Figs. 2 and 3); (iii)
IFI16 protein binds to AIM2 in the cytoplasm and the increased
levels of the IFI16 protein in transfected cells inhibit the AIM2-
ASC inflammasome-mediated activation of casapase-1 (Fig. 4); (iv)
the constitutive knockdown of the IFI16 expression in THP-1 cells
increases the basal levels of the activated casapase-1 (Fig. 5); and
(v) the knockdown of IFI16 expression increased activation of
caspase-1 by the AIM2 and NLRP3 inflammasomes (Fig. 6).
Together, these observations demonstrate that the IFN-inducible
IFI16 protein suppresses activation of caspase-1 by the AIM2 and
NLRP3 inflammasomes (Fig. 7).
Inflammasomeshave beenextensivelycharacterized inmonocytes,
macrophages, and melanoma cells [27,29,45]. Moreover, a recent
study has reported that the IFI16 protein can sense the KSHV DNA
in the nucleus to activate caspase-1 and inflammasome activity in
endothelial cells [32]. Furthermore, we recently noted that in
senescent HDFs increased levels of the AIM2 protein are associated
with the production of IL-1b [35]. Notably, the production of IL-1b
was associated with reduced levels of the IFI16 protein. Accordingly,
the knockdown of IFI16 expression in endothelial cells was associated
with increased activation of caspase-1 by vaccinia virus [32]. Given
that the knockdown of IFI16 protein expression in THP-1 cells
increased basal and poly(dA:dT)-induced activation of caspase-1
(Figs. 5 and 6A), these observations are consistent with the recent
Figure 6. Knockdown of IFI16 expression increases casapase-1 activation by the AIM2 inflammasome. (A) Control THP-1 cells (lanes 1
and 2) or cells in which we knocked down the expression of IFI16 protein (lanes 3 and 4) were incubated with PMA (20 nM) for 14 h and then treated
with LPS (1 mg/ml) for 3 h. Cells were then nucleofected without DNA (lanes 1 and 3) or with 2 mg of poly(dA:dT). After nucleofections, cells were
incubated for 1.5 h and total cell lysates containing equal amounts of proteins were analyzed by immunoblotting using antibodies specific to the
indicated proteins. The arrowheads indicate the bands corresponding to the indicated proteins. FC, indicates the fold change in the levels of the
activated caspase-1 (the p20 protein band) with respect to the control lane 1. (B) Relative levels of caspase-1 (p20) protein shown in the panel A
(lanes 1-4). (C) Control THP-1 cells (lanes 1 and 2) or cells in which we knocked down the expression of IFI16 protein (lanes 3 and 4) were incubated
with PMA (100 nM) for 3 h and then treated with LPS (1 mg/ml) for 3 h. Cells were then either left untreated (lanes 1 and 3) or treated with alum
(300 mg/ml) for 150 min. Total cell lysates containing equal amounts of proteins were analyzed by immunoblotting using antibodies specific to the
indicated proteins. FC, indicates the fold change in the levels of the pro-caspase-1 with respect to the control lane 1. (D) Relative levels of NALP3
protein shown in the panel C (lanes 1–4).
doi:10.1371/journal.pone.0027040.g006
Figure 7. Type I and type II IFNs differentially regulate the
expression of the IFI16 and AIM2 proteins. The expression of IFI16
protein suppresses activation of caspase-1 by the AIM2 inflammasome.
doi:10.1371/journal.pone.0027040.g007
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regulator of caspase-1 activation in a cells. Based on our observations,
it is conceivable that the IFI16 protein exerts its anti-inflammatory
functions by: (i) sequestering AIM2 protein through PYD (Fig. 4),
thus, inhibiting the recruitment of ASC protein and the activation of
the AIM2 inflammasome; and (ii) up-regulating the expression of IL-
10 and IFN-b (Fig. 5D), anti-inflammatory cytokines. Because the
expression of both IFI16 and AIM2 proteins is not limited to
m o n o c y t e sa n dm a c r o p h a g e s( F i g .1 ) ,i ti sl i k e l yt h a tt h er a t i ob e t w e e n
IFI16 and AIM2 protein levels in the cytoplasm of a given cell type
contributes to the decision between the production of type I IFNs and
IL-1b (and possibly cell death, ref. 15) after sensing cytosolic dsDNA
(Fig. 7).
Constitutive basal levels of mRNAs that encode for the IFI16,
AIM2, and procaspase-1 were relatively low in THP-1 cells (Fig. 2).
In contrast, the levels of mRNAs encoding for the pro-IL-1b were
detectable. Interestingly, the basal levels of procaspase-1 protein
were detectable in THP-1 cells whereas levels of pro-IL-1b were
not detectable (Fig. 3). These observations suggest a post-
transcriptional regulation of the levels of procaspase-1 and pro-
IL-1b proteins in THP-1 cells.
The knockdown of p202 expression in BMDMs increased activation
of caspase-1 by the AIM2 inflammasome [46]. Moreover, the levels of
the p202 protein in BMDMs from non lupus-prone (B6) and a lupus-
prone strain of mice (the NZB) were inversely correlated with the
activation of caspase-1 by the AIM2 inflammasome [46]. Consistent
with these observations, increased levels of the p202 protein in splenic
and bone marrow-derived cells in l u p u sp r o n es t r a i n so fm i c ew e r e
inversely correlated with the levels of the Aim2 protein and the
production of pathogenic auto-antibodies [39], which are associated
with the development of lupus-like disease [11]. Given that PBMCs
from lupus patients express increased levels of the IFI16 mRNA as
compared to healthy individuals [47], our observations that the IFI16
protein suppresses the activation of caspase-1 by the AIM2-ASC
inflammasome support the idea that the increased levels of the IFI16
protein in immune cells contribute to the development of autoimmu-
nity. Further work is in progress to test this exciting possibility.
Previous studies using cells of the hematopoietic origin had
indicated that the IFI16 protein is primarily localized in the nuclear
compartment [48]. Moreover, a recent study has noted that the
IFI16 protein is detected in the nucleus of endothelial cells [32].
However, in a human prostate epithelial cancer cell line (PC-3), the
endogenous IFI16 protein was primarily detected in the cytoplasm
[34]. Moreover, using a quantitative cell fractionation approach, we
recently noted that the bulk of the IFI16 protein was primarily
detected in the cytoplasmic fraction of normal HDFs and only a
small fraction (,25%) was detectable in the nuclear fraction [35].
Similarly, in THP-1 cells, the bulk of the IFI16 protein was detected
primarily in the cytoplasmic fraction and only a small fraction (less
than 10%) was detectable in the nuclear fraction (Fig. 3). Given that
the IFI16 protein can heterodimerize with the AIM2 protein (and
possibly other p200-family proteins) (Fig. 4; and ref. 17, 35), it is
likely that interactions of the IFI16 protein with the AIM2 protein
(and possibly with other p200-family proteins) contribute to its
cytoplasmic localization. Notably, we have detected a small fraction
(,20%) of the AIM2 protein in the nuclear fraction of normal
HDFs (35) and THP-1 cells (Fig. 3). Presently, it is not clear what
regulates the nuclear localization of AIM2 protein in THP-1 cells.
Given that IFI16 protein contains a classical nuclear localization
signalandthe protein heterodimerizeswithAIM2 protein,itislikely
that treatment of THP-1 cells with PMA and IFN-c potentiates the
nuclear localization of IFI16 protein and IFI16 protein ‘‘piggy
backs’’ the AIM2 protein to the nucleus (Fig. 3C). Further work will
be needed to address this interesting observation.
Type I IFN-treatment of the murine BMDMs induces IL-10
expression in a STAT1-dependent manner, thereby, reducing the
abundance of the pro-IL-1b levels through the activation of
STAT3 transcription factor [37]. Consistent with this observation,
we noted that type I IFN-treatment of THP-1 cells reduced steady-
state levels of pro-IL-1b mRNA (Fig. 2A), thus, raising the
possibility that the IFN-inducible IFI16 protein increases the IL-10
expression. Interestingly, the knockdown of the IFI16 expression in
THP-1 cells abrogated the type-I IFN-mediated increase in IL-10
mRNA levels (Fig. 5D). Therefore, we propose that the expression
of IFI16 protein is required for the IFN-mediated induction of IL-
10 expression and suppression of the pro-IL-1b expression.
Moreover, treatment of THP-1 cells with PMA (which induced
the levels of pro-IL-1b protein) and IFN-b decreased the levels of
pro-IL-1b protein (Fig. 3). However, the knockdown of the IFI16
expression in THP-1 cells and treatment of cells with PMA did not
result in increases in pro-IL-1b protein (Fig. 6). These observations
indicate that the PMA-induced signaling pathways regulate the
IFI16 mediated modulation of the pro-IL-1b expression in THP-1
cells. Therefore, further work is in progress to determine the
molecular mechanisms by which the IFN-inducible IFI16 protein
regulates the IL-10/STAT3/P-IL-1b pathway.
In summary, our observations demonstrate that type I and II
IFNs up-regulate the expression of IFI16 and AIM2 proteins in
THP-1 cells. However, the extent of induction by the two IFNs
varies. Moreover, we found that type I IFN treatment of THP-1
cells decreases the levels of pro-IL-1b mRNA. Significantly, our
observations demonstrate that the expression of the IFI16 protein
in THP-1 cells suppresses activation of caspase-1 by the AIM2-
ASC and NLRP3 inflammasomes. These observations will serve
basis to investigate the role of IFI16 protein in the regulation of
inflammation and associated diseases.
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